Work

Phase I study evaluating the safety and preliminary anti-tumor efficacy of receptor mediated bispecific nano-immunoengager in advanced solid tumors

Year: 2023

Type: article

Source: International Journal of Cancer Care and Delivery

DOI: 10.53876/001c.90309

Authors: Jonathan Riess, Kit Lam, Cathleen Park, Anthony Maida

Institution: UC Davis Comprehensive Cancer Center

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4389393770

FWCI:

Cites:

Cited by:

Related to: 10